CARBONE, FEDERICO
 Distribuzione geografica
Continente #
EU - Europa 15.914
Totale 15.914
Nazione #
IT - Italia 15.914
Totale 15.914
Città #
Genova 13.159
Rapallo 1.487
Genoa 1.232
Bordighera 36
Totale 15.914
Nome #
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 176
Update on cardiotoxicity of anti-cancer treatments 165
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 165
Alamandine abrogates neutrophil degranulation in atherosclerotic mice 161
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability. 156
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 154
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 153
Pathophysiology and treatments of oxidative injury in ischemic stroke: Focus on the phagocytic NADPH Oxidase 2 150
Pathophysiological role of neutrophils in acute myocardial infarction. 148
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 148
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 142
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 142
The role of adipocytokines in atherogenesis and atheroprogression. 142
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 142
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 139
Potential pathophysiological role for the vitamin D deficiency in essential hypertension. 139
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 138
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 137
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 133
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke 131
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 130
Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite 129
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 129
The Role of the Intraplaque Vitamin D System in Atherogenesis. 128
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. 128
Prognostic value of PCSK9 levels in patients with acute coronary syndromes 128
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury 127
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 126
Pre-surgery age-adjusted Charlson Comorbidity Index is associated with worse outcomes in acute cholecystitis 126
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 125
The Role of Inflammation in Cardiovascular Outcome 124
Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis 122
Pathophysiological relevance of macrophage subsets in atherogenesis 122
Update on evidence for treatment with ranolazine in stable angina. 121
Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients. 121
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis 121
Emerging pathophysiological relevance for neutrophils in acute coronary syndromes. 120
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis 119
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 117
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function 117
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 117
The Role of Adipocytokines in Coronary Atherosclerosis 116
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 116
The Pathophysiological Role of Neutrophil Extracellular Traps in Inflammatory Diseases 116
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis 116
Leptin/adiponectin ratio predicts post-stroke neurological outcome 115
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages 115
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments 114
Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials 114
High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy 114
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures 114
Pericardial adipose tissue and cardiovascular diseases: new insights from basic research 113
The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis 113
Impact of Endocrine Disorders on Vasculature 112
Adipose Tissue Composition in Obesity and After Bariatric Surgery 112
The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation 111
Clinical relevance of adverse intracerebral artery remodeling in patients with HIV 110
The need of identifying circulating biomarkers of coronary dysfunction 110
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 110
Reply to "Precipitants of heart failure must be fully considered when predicting readmission" 109
Update on the efficacy of statin treatment in Acute Coronary Syndromes. 109
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis. 108
Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure 107
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 105
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases. 104
Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration 103
Protective role of necrostatin-1 in acute myocardial infarction 103
New insights on the role of DNA methylation in cardiovascular disease 103
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer 103
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. 102
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis. 102
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 102
4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability 101
Oxidative burden in familial hypercholesterolemia 101
Obesity phenotypes and their paradoxical association with cardiovascular diseases 101
Impact of different ectopic fat depots on cardiovascular and metabolic diseases 100
Mitochondria in liver diseases 100
Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis. 99
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice 99
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 99
Reply to “Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway” 99
Treatment with sulphated galactan is associated with reduced macrophage chemotaxis, potentially preventing atherosclerotic plaque development 98
The pathophysiological role of cholecystokinin-1 receptor in mouse cholelithogenesis 97
Research update for articles published in EJCI in 2016 96
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 95
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence 95
Research update for articles published in EJCI in 2014 94
Change in inferior vena cava minimum diameter during hospitalization predicts the readmission in patients with severe systolic heart failure 92
Inflammation in arterial diseases. 92
Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases 92
A critical role of Pentraxin 3 in severe sepsis and septic shock 92
Diabetes and Vascular Disease: is it all about Glycemia? 92
Monocyte count at onset predicts post-stroke outcomes during a 90-day follow up 91
Novel cardiovascular risk biomarkers in carotid atherogenesis 91
Biophysical aspects and novel treatments of atrial fibrillation 90
Radiologic Cerebral Reperfusion at 24 h Predicts Good Clinical Outcome 89
Serum levels of osteopontin predict diabetes remission after bariatric surgery 89
Mitochondria targeting to oppose the progression of nonalcoholic fatty liver disease 89
Reply to "PCSK9: Entering a new era of cardiovascular risk prediction" 89
Targeting Inflammation in Primary Cardiovascular Prevention 88
Totale 11.609
Categoria #
all - tutte 50.018
article - articoli 49.023
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 995
Totale 100.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019781 0 0 0 0 0 0 0 0 0 0 359 422
2019/20206.240 236 116 145 714 582 824 1.022 567 590 774 468 202
2020/20212.482 155 211 232 346 189 160 123 281 170 289 122 204
2021/20222.286 84 97 128 226 105 201 117 496 222 235 101 274
2022/20231.867 218 105 29 164 279 289 2 164 355 8 214 40
2023/2024964 56 133 36 131 105 193 85 91 70 56 8 0
Totale 16.845